{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T04:17:56Z","timestamp":1742444276979,"version":"3.40.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["18\/00837-1"],"award-info":[{"award-number":["18\/00837-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Neurological manifestations are present in about one-third of COVID-19 cases, ranging from mild symptoms, such as anosmia, to more severe forms like demyelinating syndromes. Although direct invasion of the CNS has been demonstrated, the immune- mediated pathway is also described and more accepted. Even in cases where viral detection in CSF is absent, it should not rule out neuroinvasion. There are few prospective studies about neurological manifestations of COVID-19, especially with viral tests in CSF; as well there are still many questions about COVID-19 associated with neurological disease. Thus, we describe clinical and CSF findings of a prospective cohort of patients with nasal positive tests for SARS-CoV-2 and neurological involvement. We also discuss the pathogenic mechanisms related to these manifestations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and Findings<\/jats:title>\n<jats:p>This is a prospective cohort study; 27 patients were evaluated according to clinical presentation, the time interval between COVID-19 diagnosis and onset of neurological alterations, syndromic diagnosis, imaging and CSF findings. Real time polymerase chain reaction for SARS-CoV-2 genome was performed in all CSF samples. 2 RT-PCR in spinal cord fluid resulted positive in 9 (33.3%) cases, five of them had a positive swab nasal test concomitant to neurologic disease. Respiratory signs were described in 12 out 27 patients, five of them with viral detection in CSF. White cell counts in CSF were normal range in the majority of cases, except for 3 occurrences: two patients had elevated CSF WBC counts and viral detection in CSF (10 and 36 cells\/mm3) and one also had elevated CSF WBC count but viral detection in CSF was negative (21cells\/mm3). The observed neurological signs encompassed a diverse neurologic spectrum, including seizures, paresis, gait abnormalities, headaches, alteration in consciousness and memory or cognitive impairment. Both imaging and CSF alterations exhibited non-specific characteristics. Syndromic diagnoses included stroke, dementia or cognitive impairments, Guillain-Barr\u00e9 Syndrome, encephalitis, encephalomyelitis, acute flaccid palsy and optical neuritis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The patients in the present study had COVID-19 and neurologic involvement including a wide range of clinical manifestations. SARS-CoV-2 was detected in one-third of CSF samples, regardless of time interval between COVID-19 diagnosis and the onset of neurological signs. These conditions encompass various pathogenic pathways and the neuroinvasion potential of SARS-CoV-2 should be more studied.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0312621","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:50:36Z","timestamp":1742406636000},"page":"e0312621","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurologic manifestations of COVID-19 and viral test in cerebrospinal fluid"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6046-8658","authenticated-orcid":true,"given":"Carla de Oliveira","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandra Strazza","family":"Rodrigues Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Beatriz Moreira","family":"de Oliveira Chagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya Jabur","family":"Badra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimas Tadeu","family":"Covas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Kashima","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Tadeu Moraes","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"12","key":"pone.0312621.ref001","first-page":"e32297","article-title":"A case of transverse myelitis secondary to COVID-19 infection","volume":"14","author":"R Borra","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"pone.0312621.ref002","first-page":"e29521","article-title":"Atypical guillain-barr\u00e9 syndrome presenting after COVID-19 infection","volume":"14","author":"A Noon","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"pone.0312621.ref003","first-page":"e23877","article-title":"A rare case of myelin oligodendrocyte glycoprotein antibody-associated transverse myelitis in a 40-year-old patient with COVID-19","volume":"14","author":"SG Doukas","year":"2022","journal-title":"Cureus"},{"issue":"7","key":"pone.0312621.ref004","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/v15071598","article-title":"Cerebrovascular disease in COVID-19","volume":"15","author":"J Siegler","year":"2023","journal-title":"Viruses"},{"key":"pone.0312621.ref005","doi-asserted-by":"crossref","first-page":"111200","DOI":"10.1016\/j.biopha.2020.111200","article-title":"The neuropsychiatric manifestations of COVID-19: interactions with psychiatric illness and pharmacological treatment","volume":"135","author":"E Jansen van Vuren","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"pone.0312621.ref006","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"L Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"pone.0312621.ref007","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/10790268.2021.1969502","article-title":"Acute cerebellitis, transverse myelitis and polyradiculoneuritis related to post-COVID-19 infection","volume":"45","author":"\u00dcT B\u00f6r\u00fc","year":"2022","journal-title":"J Spinal Cord Med"},{"issue":"5","key":"pone.0312621.ref008","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.12998\/wjcc.v9.i5.1058","article-title":"Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic","volume":"9","author":"L Huo","year":"2021","journal-title":"World J Clin Cases"},{"key":"pone.0312621.ref009","doi-asserted-by":"crossref","first-page":"102917","DOI":"10.1016\/j.msard.2021.102917","article-title":"COVID-19 and emerging spinal cord complications: A systematic review","volume":"51","author":"R Mondal","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"pone.0312621.ref010","author":"K Heuser","year":"28 de junho de 2021"},{"issue":"9","key":"pone.0312621.ref011","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/epi.16656","article-title":"COVID-19 and seizures: Is there a link?","volume":"61","author":"D Vohora","year":"2020","journal-title":"Epilepsia"},{"issue":"4","key":"pone.0312621.ref012","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.7861\/clinmed.2020-0213","article-title":"Guillain-Barr\u00e9 syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection","volume":"20","author":"A Sancho-Salda\u00f1a","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"pone.0312621.ref013","doi-asserted-by":"crossref","first-page":"1099458","DOI":"10.3389\/fneur.2023.1099458","article-title":"Case report: A case of acute disseminated encephalomyelitis after SARS-CoV-2 infection in pediatric patients","volume":"14","author":"F Cautilli","year":"2023","journal-title":"Front Neurol"},{"issue":"4","key":"pone.0312621.ref014","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.36740\/WLek202104144","article-title":"Acute transverse myelitis as a neurological complication of COVID-19: A case report","volume":"74","author":"HV Palahuta","year":"2021","journal-title":"Wiadomosci Lek"},{"issue":"12","key":"pone.0312621.ref015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11910-020-01079-7","article-title":"Central nervous system manifestations associated with COVID-19","volume":"20","author":"A Divani","year":"2020","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"7","key":"pone.0312621.ref016","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/01616412.2021.2024732","article-title":"Neurological manifestations and pathogenic mechanisms of COVID-19","volume":"44","author":"M Galea","year":"2022","journal-title":"Neurol Res"},{"issue":"2","key":"pone.0312621.ref017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00415-021-10752-x","article-title":"Association of CNS demyelination and COVID-19 infection: an updated systematic review","volume":"269","author":"II Ismail","year":"2022","journal-title":"J Neurol"},{"issue":"2","key":"pone.0312621.ref018","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10072-020-04946-w","article-title":"Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series","volume":"42","author":"RL Tuma","year":"2021","journal-title":"Neurol Sci"},{"issue":"9","key":"pone.0312621.ref019","first-page":"e17896","article-title":"Acute inflammatory demyelinating polyneuropathy with bowel and bladder incontinence following COVID-19 infection","volume":"13","author":"V Letchuman","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"pone.0312621.ref020","doi-asserted-by":"crossref","first-page":"e246967","DOI":"10.1136\/bcr-2021-246967","article-title":"A possible Guillain-Barr\u00e9 syndrome\/transverse myelitis overlap syndrome after recent COVID-19","volume":"15","author":"R Alrubaye","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"4","key":"pone.0312621.ref021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1515\/revneuro-2021-0082","article-title":"Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies","volume":"33","author":"R Zamani","year":"2022","journal-title":"Rev Neurosci"},{"key":"pone.0312621.ref022","doi-asserted-by":"crossref","first-page":"117316","DOI":"10.1016\/j.jns.2021.117316","article-title":"Cerebrospinal fluid in COVID-19: A systematic review of the literature","volume":"421","author":"A Lewis","year":"2021","journal-title":"J Neurol Sci"},{"issue":"5","key":"pone.0312621.ref023","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3390\/ijms22052681","article-title":"Interactions of SARS-CoV-2 with the Blood-Brain Barrier","volume":"22","author":"MA Erickson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0312621.ref024","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clinimag.2021.10.003","article-title":"Brain MRI findings in COVID-19 patients with PRES: A systematic review","volume":"81","author":"R Yeahia","year":"2022","journal-title":"Clin Imaging"},{"issue":"21","key":"pone.0312621.ref025","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","article-title":"The neurobiology of long COVID","volume":"110","author":"M Monje","year":"2022","journal-title":"Neuron"},{"key":"pone.0312621.ref026","doi-asserted-by":"crossref","first-page":"577939","DOI":"10.1016\/j.jneuroim.2022.577939","article-title":"Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review","volume":"371","author":"P Feizi","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"4","key":"pone.0312621.ref027","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S2666-5247(20)30066-5","article-title":"Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic","volume":"1","author":"G Destras","year":"2020","journal-title":"Lancet Microbe"},{"issue":"1","key":"pone.0312621.ref028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-021-02339-0","article-title":"Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients","volume":"19","author":"S Jarius","year":"2022","journal-title":"J Neuroinflammation"},{"key":"pone.0312621.ref029","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13195-020-00744-w","article-title":"Cognitive impact of COVID-19: looking beyond the short term","volume":"12","author":"S Miners","year":"2020","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"3","key":"pone.0312621.ref030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11910-021-01102-5","article-title":"Peripheral nervous system manifestations associated with COVID-19","volume":"21","author":"S Andalib","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"pone.0312621.ref031","doi-asserted-by":"crossref","first-page":"20406223221076890","DOI":"10.1177\/20406223221076890","article-title":"Neurological manifestations of long-COVID syndrome: a narrative review","volume":"13","author":"M-I Stefanou","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"6","key":"pone.0312621.ref032","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tcm.2022.04.004","article-title":"COVID-19 and the brain","volume":"32","author":"KS Hingorani","year":"2022","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"pone.0312621.ref033","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/cells12050816","article-title":"Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics","volume":"12","author":"A Leng","year":"2023","journal-title":"Cells"},{"issue":"2","key":"pone.0312621.ref034","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.stemcr.2021.12.011","article-title":"The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2","volume":"17","author":"S Krasemann","year":"2022","journal-title":"Stem Cell Rep"},{"key":"pone.0312621.ref035","doi-asserted-by":"crossref","first-page":"102608","DOI":"10.1016\/j.conb.2022.102608","article-title":"Neuroinflammation and COVID-19","volume":"76","author":"A Vanderheiden","year":"2022","journal-title":"Curr Opin Neurobio"},{"issue":"6","key":"pone.0312621.ref036","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00115-021-01077-1","article-title":"Neuroimmunologie von COVID\u201119","volume":"92","author":"T Skripuletz","year":"2021","journal-title":"Nervenarzt"},{"key":"pone.0312621.ref037","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2022.07.010","article-title":"Neurological complications in children hospitalized with seizures and respiratory infections: A comparison between SARS-CoV-2 and other respiratory infections","volume":"135","author":"G Gombolay","year":"2022","journal-title":"Pediatric Neurology"},{"issue":"9","key":"pone.0312621.ref038","doi-asserted-by":"crossref","first-page":"e249156","DOI":"10.1136\/bcr-2022-249156","article-title":"Cerebral microvascular injuries in severe COVID-19 infection: progression of white matter hyperintensities post-infection","volume":"15","author":"I Petersson","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"10","key":"pone.0312621.ref039","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/PHM.0000000000001857","article-title":"clinical features, laboratory, and radiological findings of patients with acute inflammatory myelopathy after COVID-19 infection: a narrative review","volume":"100","author":"A Barman","year":"2021","journal-title":"Am J Phys Med Rehabil"},{"issue":"12","key":"pone.0312621.ref040","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1007\/s00415-021-10611-9","article-title":"COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2","volume":"268","author":"S Sriwastava","year":"2021","journal-title":"J Neurol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:52:28Z","timestamp":1742406748000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312621"}},"subtitle":[],"editor":[{"given":"Kartikeya","family":"Rajdev","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0312621","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}